封面
市場調查報告書
商品編碼
1663459

集中式患者監測系統市場,按患者數量、按最終用戶、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率及預測

Centralized Patient Monitoring System Market, By Number of Patients, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年集中式病人監測系統市場規模價值為 6.145 億美元,2025 年至 2032 年期間的複合年成長率為 7.10%。

集中式病人監護系統市場-市場動態

改善醫療基礎設施

在全球範圍內,改善醫療保健基礎設施對於促進集中式病人監測系統的使用和有效性至關重要。醫療機構在基礎設施現代化升級的過程中,經常會投資於能夠實現集中監控功能的尖端技術。為了促進部門和醫療保健提供者之間的資料流,這需要建立可互通的系統,整合電子健康記錄 (EHR),並建立強大的 IT 框架。這些改進使得在多個地點即時監控患者變得更加容易,從而保證及時治療並改善治療效果。此外,醫療保健基礎設施的改善也支持集中監控患者所需的先進醫療設備和感測器的部署。現代醫院和醫療機構擴大配備先進的監測設備,可以輕鬆記錄生理資料和生命徵象。這些發展提高了患者數據的準確性和可靠性,同時也使醫務人員能夠迅速果斷地採取行動,從而全面提高患者護理的標準。

集中式病人監護系統市場-關鍵見解

根據我們的研究分析師的分析,預測期內(2025-2032 年),全球市場預計年複合成長率約為 7.10%

根據患者人數細分,預計患者人數<16 的類別將在 2024 年佔據最大市場佔有率

根據最終用途細分,醫院將成為 2024 年的主要細分市場

從地區來看,北美是 2024 年最大的收入來源

集中式病人監測系統市場-細分分析:

全球集中式病人監測系統市場根據患者數量、最終用戶和地區進行細分。

根據患者數量,市場分為<16 名患者、17-32 名患者、33-64 名患者和>64 名患者。到 2024 年,市場將以患者人數少於 16 人的類別為主。醫院專科護理單位、門診部和小型診所是監測少於 16 名患者的系統的主要使用者。這些配置通常使用小型集中監控站或軟體平台,與少量穿戴式裝置或床邊監視器互動。對於特定數量的患者,它們提供關鍵的監測功能,保證持續的生命徵象監測,並在發生危機或其他重大事件時及時向醫療專業人員發出警報。

根據最終用戶,市場分為醫院、創傷中心、門診手術中心和其他。在這個市場中,醫院佔據著最大的佔有率。他們使用集中式病人監控系統來監控不同部門和單位的各種病人狀況。這些系統對於急診室、普通病房、重症監護室 (ICU) 和手術室至關重要,因為這些地方需要持續的生命徵象和病患狀態監測,以便及時介入和有效的臨床管理。電子健康記錄 (EHR)、遙測系統和床邊監視器都與醫院的集中監測站整合。這使得醫療專業人員能夠追蹤患者趨勢,最佳化工作流程,並改善護理協調,以獲得更好的患者治療結果。

集中式病人監護系統市場-地理洞察

2024 年,北美在全球集中式病人監護系統市場佔據主導地位,其特點是強大的醫療保健系統、廣泛使用尖端醫療技術以及嚴格的監管環境。高昂的醫療成本、技術進步以及對病人安全和護理品質的關注是推動北美(尤其是美國和加拿大)集中式患者監測系統市場發展的主要因素。為了改善臨床決策、簡化工作流程和改善病患治療效果,這些地區率先在醫院、ASC 和創傷中心採用集中監控解決方案。這些解決方案整合了先進的遙測系統、床邊監視器和集中監控站。

然而,在整個預測期內,預計亞太地區將出現最快的複合年成長率,這得益於基礎設施支出的成長、醫療保健投資的增加以及數位健康技術的日益廣泛的使用。為了增加醫療機會和提高醫療質量,中國、印度和日本等國家正在投資遠距醫療、遠距病人監控和智慧醫療計畫。亞太地區的集中監控系統支援即時病人監控、資料分析和遠距醫療服務,滿足從遠距診所到城市醫院的一系列醫療保健需求。該地區對技術整合和醫療保健創新的重視,為尋求擴大影響力和應對不斷變化的醫療保健問題的市場參與者提供了巨大的成長前景。

集中式病人監測系統市場-競爭格局:

在競爭激烈的集中病人監護系統產業中,存在著許多重要的競爭對手。為了提高市場地位,產業內的公司專注於研發、產品發布、策略聯盟和併購。集中式病人監護系統市場的領導公司包括飛利浦醫療集團 (Philips Healthcare)、荷蘭皇家飛利浦公司 (Koninklijke Philips NV)、Infinium Medical、環球醫療儀器 (Universal Medical Instruments) 和通用電氣醫療集團 (GE Healthcare) 等。為了滿足消費者和醫療保健日益成長的需求,這些行業參與者也一直在尋求投資和創新。例如,2023年5月,美國食品藥物管理局(FDA)批准了雅培的Assert-IQTM可植入心臟監視器(ICM),為心律不整患者提供了長期監測和診斷評估的新選擇。透過此項批准,雅培能夠協助醫生遠端管理和治療患者的連網醫療設備產品線得到了擴展。

近期發展

2024 年 11 月:FDA 批准 GE HealthCare 將 Novii+ 產婦和胎兒監測系統擴大用於懷孕 34 週或以上的孕婦。 Novii+ 透過非侵入性測量和顯示子宮活動、孕婦心率和胎兒心率,為患者在醫院期間提供舒適性和機動性。

2023 年 1 月:Senet 和 Telli Health 推出了首款支援 LoRaWAN 的遠端病人監控 (RPM) 設備。透過使醫療從業者能夠聯繫到更多位於服務不足和偏遠地區(如原住民社區)的患者,這項技術將提高醫療保健的公平性和包容性,並為未來的智慧家庭服務奠定基礎。

目錄

第 1 章:集中式病患監護系統市場概述

  • 研究範圍
  • 市場估計年限

第 2 章:執行摘要

  • 市場片段
    • 集中式病患監測系統市場片段(依病患數量)
    • 集中式病患監測系統市場片段(依最終使用者)
    • 集中式病患監測系統市場片段(依國家/地區)
    • 集中式病患監護系統市場片段(按區域)
  • 競爭洞察

第 3 章:集中式病患監測系統關鍵市場趨勢

  • 集中式病人監護系統市場促進因素
    • 市場促進因素的影響分析
  • 集中式病患監測系統市場限制
    • 市場限制的影響分析
  • 集中式病人監護系統市場機會
  • 集中式病人監護系統市場未來趨勢

第 4 章:集中式病患監護系統產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章:集中式病患監測系統市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠肺炎疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長領域
    • 最失敗的部分
    • 邊際損失市場區隔

第 6 章:集中式病患監測系統市場格局

  • 2024 年集中式病患監測系統市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章:集中式病患監測系統市場 - 依病患數量

  • 概述
    • 按患者數進行細分佔有率分析
    • 患者人數<16
    • 17-32 病患人數
    • 33-64 歲患者人數
    • >64 名患者

第 8 章:集中式病患監測系統市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 創傷中心
    • 門診手術中心
    • 其他

第 9 章:集中式病患監護系統市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美集中式病人監護系統主要製造商
    • 北美市場規模及預測(按國家/地區)
    • 北美市場規模及預測(按患者數)
    • 北美市場規模及預測(依最終用戶分類)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲集中式病人監護系統主要製造商
    • 歐洲市場規模及預測(按國家)
    • 歐洲市場規模及預測(按患者數)
    • 歐洲市場規模及預測(按最終用戶)
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區集中式病患監護系統主要製造商
    • 亞太地區市場規模及預測(依國家)
    • 亞太市場規模及預測(依患者數)
    • 亞太市場規模及預測(依最終用戶)
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲集中式病患監測系統主要製造商
    • 拉丁美洲市場規模及預測(按國家/地區)
    • 拉丁美洲市場規模及預測(按患者數)
    • 拉丁美洲市場規模及預測(按最終用戶分類)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲集中式病人監護系統主要製造商
    • 中東和非洲市場規模及預測(按國家/地區)
    • 中東和非洲市場規模及預測(按患者數)
    • 中東和非洲市場規模及預測(按最終用戶分類)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 10 章:主要供應商分析-集中式病患監測系統產業

  • 競爭儀錶板
  • 公司簡介
    • Philips Healthcare
    • Koninklijke Philips NV
    • Infinium Medical
    • Universal Medical Instruments
    • GE Healthcare
    • Abbott Laboratories
    • Nihon Kohden Corporation
    • Nihon Kohden
    • Sunray
    • Mediana
    • MindRay
    • Criticare Systems Inc.
    • Honeywell International Inc.
    • Others

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4634

REPORT HIGHLIGHT

Centralized Patient Monitoring System Market size was valued at US$ 614.5 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Centralized patient monitoring systems are made up of a network of interconnected medical equipment and software that make it possible to continuously monitor and gather vital signs and other pertinent information from patients. Healthcare professionals can access real-time patient data using these technologies, identify important changes, and make prompt therapeutic decisions. Healthcare providers can increase productivity, monitor more patients at once, and improve patient outcomes by centralizing patient data. The growing demand for remote patient monitoring, improvements in medical technology, and an increased emphasis on enhancing patient outcomes are all driving the market for centralized patient monitoring systems. Among the many advantages of centralized patient monitoring systems are ongoing patient observation, early anomaly identification, and prompt intervention. However, obstacles like interoperability problems, data security concerns, and the demand for qualified healthcare workers could impede the centralized patient monitoring systems industry expansion. Nevertheless, the market offers chances for manufacturers, healthcare providers, and tech developers to create cutting-edge centralized patient monitoring systems and revolutionize the way healthcare is delivered.

Centralized Patient Monitoring System Market- Market Dynamics

Improved Healthcare Infrastructure

Globally, improved healthcare infrastructure is essential to promoting the use and effectiveness of centralized patient monitoring systems. Healthcare facilities frequently make investments in cutting-edge technologies that enable centralized monitoring capabilities as they modernize their infrastructure. In order to facilitate data flow between departments and healthcare providers, this entails putting in place interoperable systems, integrating electronic health records (EHRs), and building strong IT frameworks. These improvements make it easier to monitor patients in real-time across several locations, guaranteeing prompt treatments and improved therapeutic results. Additionally, the deployment of advanced medical equipment and sensors required for centralized patient monitoring is supported by improved healthcare infrastructure. Modern hospitals and healthcare facilities are increasingly outfitted with cutting-edge monitoring devices that can easily record physiological data and vital signs. These developments improve patient data's accuracy and dependability while also empowering medical personnel to act quickly and decisively, which raises the standard of patient care overall.

Centralized Patient Monitoring System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on the number of patients segmentation, the <16 number of patients category was predicted to show the maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Centralized Patient Monitoring System Market- Segmentation Analysis:

The Global Centralized Patient Monitoring System Market is segmented on the basis of Number of Patients, End-user, and Region.

On the basis of number of patients, the market is segregated into <16 number of patients, 17-32 number of patients, 33-64 number of patients, and >64 number of patients. In 2024, the market was dominated by the <16 number of patients category. Hospital-specialized care units, outpatient departments, and tiny clinics are the main users of systems made for monitoring fewer than 16 patients. These configurations usually make use of small, centralized monitoring stations or software platforms that interface with a small number of wearables or bedside monitors. For a specific number of patients, they offer crucial monitoring capabilities that guarantee ongoing vital sign surveillance and timely alerting of medical professionals in the event of crises or other significant occurrences.

Based on end-user, the market is divided into Hospitals, Trauma Centers, Ambulatory Surgical centers, and Others. In this market, hospitals make up the largest segment. They use centralized patient monitoring systems to monitor a variety of patient statuses in different departments and units. These systems are essential in emergency rooms, general wards, intensive care units (ICUs), and operating theatres where ongoing vital signs and patient status monitoring are necessary for prompt intervention and efficient clinical management. Electronic health records (EHRs), telemetry systems, and bedside monitors are all integrated with centralized monitoring stations in hospitals. This allows medical professionals to track patient trends, optimize workflow, and improve care coordination for better patient outcomes.

Centralized Patient Monitoring System Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Centralized Patient Monitoring Systems, distinguished by strong healthcare systems, widespread use of cutting-edge medical technology, and strict regulatory environments. High healthcare costs, technology advancements, and a focus on patient safety and care quality are the main factors driving the market for centralized patient monitoring systems in North America, especially in the US and Canada. In order to improve clinical decision-making, streamline workflow, and enhance patient outcomes, these regions are at the forefront of the adoption of centralized monitoring solutions across hospitals, ASCs, and trauma centres. These solutions integrate advanced telemetry systems, bedside monitors, and centralized monitoring stations.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by growing infrastructure spending, increased investments in healthcare, and the growing use of digital health technologies. To increase access to and the quality of healthcare, nations like China, India, and Japan are investing in telemedicine, remote patient monitoring, and smart healthcare projects. Real-time patient monitoring, data analytics, and telemedicine services are supported by centralized monitoring systems in Asia Pacific, which serve a range of healthcare requirements from distant clinics to urban hospitals. The region's emphasis on technology integration and healthcare innovation offers significant growth prospects for market participants looking to broaden their reach and tackle changing healthcare issues.

Centralized Patient Monitoring System Market- Competitive Landscape:

There are a number of important competitors in the fiercely competitive centralized patient monitoring system industry. To improve their market position, companies in the industry concentrate on R&D, product launches, strategic alliances, and mergers and acquisitions. Among the leading companies in the market for centralized patient monitoring systems are Philips Healthcare, Koninklijke Philips N.V., Infinium Medical, Universal Medical Instruments, and GE Healthcare, among others. In order to meet the growing demands of consumers and healthcare, these industry participants are also always looking for investments and innovations. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) approved Abbott's Assert-IQTM insertable cardiac monitor (ICM), providing patients with irregular heartbeats with a new alternative for long-term monitoring and diagnostic evaluation. With this approval, Abbott's line of linked medical devices that can assist physicians in remotely managing and treating patients is expanded.

Recent Development

November 2024: The FDA has approved GE HealthCare's expanded use of the Novii+ maternal and fetal monitoring system for expectant mothers who are 34 weeks or more along. Novii+ gives patients comfort and mobility in the hospital by noninvasively measuring and displaying uterine activity, maternal heart rate, and fetal heart rate.

January 2023: Senet and Telli Health introduced the first LoRaWAN-enabled remote patient monitoring (RPM) devices. By enabling healthcare practitioners to contact more patients in underserved and remote places, such as indigenous communities, this technology will improve healthcare fairness and inclusivity and lay the groundwork for future smart home services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Philips Healthcare
  • Koninklijke Philips N.V.
  • Infinium Medical
  • Universal Medical Instruments
  • GE Healthcare
  • Abbott Laboratories
  • Nihon Kohden Corporation
  • Nihon Kohden
  • Sunray
  • Mediana
  • MindRay
  • Criticare Systems Inc.
  • Honeywell International Inc.
  • Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY NUMBER OF PATIENTS- MARKET ANALYSIS, 2019 - 2032

  • <16 number of patients
  • 17-32 number of patients
  • 33-64 number of patients
  • >64 number of patients

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Trauma Centers
  • Ambulatory Surgical centers
  • Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Centralized Patient Monitoring System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Centralized Patient Monitoring System Market Snippet by Number of Patients
    • 2.1.2. Centralized Patient Monitoring System Market Snippet by End-user
    • 2.1.3. Centralized Patient Monitoring System Market Snippet by Country
    • 2.1.4. Centralized Patient Monitoring System Market Snippet by Region
  • 2.2. Competitive Insights

3. Centralized Patient Monitoring System Key Market Trends

  • 3.1. Centralized Patient Monitoring System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Centralized Patient Monitoring System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Centralized Patient Monitoring System Market Opportunities
  • 3.4. Centralized Patient Monitoring System Market Future Trends

4. Centralized Patient Monitoring System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Centralized Patient Monitoring System Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Centralized Patient Monitoring System Market Landscape

  • 6.1. Centralized Patient Monitoring System Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Centralized Patient Monitoring System Market - By Number of Patients

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Number of Patients, 2024 & 2032 (%)
    • 7.1.2. <16 number of patients
    • 7.1.3. 17-32 number of patients
    • 7.1.4. 33-64 number of patients
    • 7.1.5. >64 number of patients

8. Centralized Patient Monitoring System Market - By End-user

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Trauma Centers
    • 8.1.4. Ambulatory Surgical centers
    • 8.1.5. Others

9. Centralized Patient Monitoring System Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Centralized Patient Monitoring System Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Centralized Patient Monitoring System Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Centralized Patient Monitoring System Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Centralized Patient Monitoring System Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Centralized Patient Monitoring System Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Centralized Patient Monitoring System Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Philips Healthcare
    • 10.2.2. Koninklijke Philips N.V.
    • 10.2.3. Infinium Medical
    • 10.2.4. Universal Medical Instruments
    • 10.2.5. GE Healthcare
    • 10.2.6. Abbott Laboratories
    • 10.2.7. Nihon Kohden Corporation
    • 10.2.8. Nihon Kohden
    • 10.2.9. Sunray
    • 10.2.10. Mediana
    • 10.2.11. MindRay
    • 10.2.12. Criticare Systems Inc.
    • 10.2.13. Honeywell International Inc.
    • 10.2.14. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us